Total Payments
$741,919
2020 Payments
$37,008
Companies
8
Transactions
775
Payment Breakdown by Category
Other$548,808 (74.0%)
Travel$115,960 (15.6%)
Consulting$57,348 (7.7%)
Food & Beverage$18,415 (2.5%)
Research$1,296 (0.2%)
Education$92.95 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $542,498 | 174 | 73.1% |
| Travel and Lodging | $115,960 | 276 | 15.6% |
| Consulting Fee | $57,348 | 12 | 7.7% |
| Food and Beverage | $18,415 | 306 | 2.5% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $4,165 | 1 | 0.6% |
| Honoraria | $2,145 | 1 | 0.3% |
| Unspecified | $1,296 | 4 | 0.2% |
| Education | $92.95 | 1 | 0.0% |
Payments by Type
General
$740,623
771 transactions
Research
$1,296
4 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GENZYME CORPORATION | $362,344 | 344 | $0 (2020) |
| Novartis Pharmaceuticals Corporation | $205,526 | 214 | $0 (2019) |
| EMD Serono, Inc. | $93,759 | 126 | $0 (2020) |
| Genentech USA, Inc. | $47,531 | 37 | $0 (2019) |
| Alexion Pharmaceuticals, Inc. | $16,508 | 28 | $0 (2019) |
| Celgene Corporation | $15,662 | 21 | $0 (2018) |
| Biogen, Inc. | $467.43 | 4 | $0 (2020) |
| Amgen Inc. | $121.86 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2020 | $37,008 | 45 | EMD Serono, Inc. ($33,383) |
| 2019 | $217,390 | 234 | GENZYME CORPORATION ($106,401) |
| 2018 | $197,458 | 198 | GENZYME CORPORATION ($106,765) |
| 2017 | $290,064 | 298 | GENZYME CORPORATION ($145,656) |
All Payment Transactions
775 individual payment records from CMS Open Payments — Page 1 of 31
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/11/2020 | EMD Serono, Inc. | Mavenclad (Drug) | Food and Beverage | In-kind items and services | $19.82 | General |
| Category: Neurology | ||||||
| 11/10/2020 | EMD Serono, Inc. | Mavenclad (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,100.00 | General |
| Category: Neurology | ||||||
| 08/19/2020 | EMD Serono, Inc. | Mavenclad (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $860.00 | General |
| Category: Neurology | ||||||
| 06/04/2020 | EMD Serono, Inc. | Mavenclad (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $860.00 | General |
| Category: Neurology | ||||||
| 06/04/2020 | EMD Serono, Inc. | Mavenclad (Drug) | Travel and Lodging | In-kind items and services | $24.85 | General |
| Category: Neurology | ||||||
| 05/14/2020 | EMD Serono, Inc. | Mavenclad (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $645.00 | General |
| Category: Neurology | ||||||
| 02/27/2020 | EMD Serono, Inc. | Mavenclad (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,160.00 | General |
| Category: Neurology | ||||||
| 02/27/2020 | EMD Serono, Inc. | Mavenclad (Drug) | Travel and Lodging | In-kind items and services | $55.55 | General |
| Category: Neurology | ||||||
| 02/27/2020 | EMD Serono, Inc. | Mavenclad (Drug) | Food and Beverage | In-kind items and services | $26.78 | General |
| Category: Neurology | ||||||
| 02/19/2020 | EMD Serono, Inc. | Mavenclad (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $860.00 | General |
| Category: Neurology | ||||||
| 02/08/2020 | GENZYME CORPORATION | AUBAGIO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,532.00 | General |
| Category: Neurology | ||||||
| 02/08/2020 | GENZYME CORPORATION | AUBAGIO (Drug) | Travel and Lodging | In-kind items and services | $415.90 | General |
| Category: Neurology | ||||||
| 02/08/2020 | GENZYME CORPORATION | AUBAGIO (Drug) | Travel and Lodging | In-kind items and services | $214.25 | General |
| Category: Neurology | ||||||
| 02/08/2020 | GENZYME CORPORATION | AUBAGIO (Drug) | Food and Beverage | In-kind items and services | $121.90 | General |
| Category: Neurology | ||||||
| 02/08/2020 | GENZYME CORPORATION | AUBAGIO (Drug) | Travel and Lodging | In-kind items and services | $100.64 | General |
| Category: Neurology | ||||||
| 02/08/2020 | GENZYME CORPORATION | AUBAGIO (Drug) | Food and Beverage | In-kind items and services | $60.00 | General |
| Category: Neurology | ||||||
| 02/08/2020 | GENZYME CORPORATION | AUBAGIO (Drug) | Travel and Lodging | Cash or cash equivalent | $36.00 | General |
| Category: Neurology | ||||||
| 02/08/2020 | GENZYME CORPORATION | AUBAGIO (Drug) | Food and Beverage | Cash or cash equivalent | $24.40 | General |
| Category: Neurology | ||||||
| 02/08/2020 | GENZYME CORPORATION | AUBAGIO (Drug) | Travel and Lodging | Cash or cash equivalent | $16.79 | General |
| Category: Neurology | ||||||
| 02/03/2020 | EMD Serono, Inc. | Mavenclad (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $860.00 | General |
| Category: Neurology | ||||||
| 01/25/2020 | EMD Serono, Inc. | Mavenclad (Drug) | Travel and Lodging | In-kind items and services | $642.20 | General |
| Category: Neurology | ||||||
| 01/25/2020 | EMD Serono, Inc. | Mavenclad (Drug) | Food and Beverage | In-kind items and services | $52.59 | General |
| Category: Neurology | ||||||
| 01/25/2020 | EMD Serono, Inc. | Mavenclad (Drug) | Food and Beverage | In-kind items and services | $31.73 | General |
| Category: Neurology | ||||||
| 01/25/2020 | EMD Serono, Inc. | Mavenclad (Drug) | Food and Beverage | In-kind items and services | $23.01 | General |
| Category: Neurology | ||||||
| 01/25/2020 | EMD Serono, Inc. | Mavenclad (Drug) | Food and Beverage | In-kind items and services | $15.77 | General |
| Category: Neurology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| CAMMS323 - CARE-MS I, CAMMS324 - CARE-MS II, and CAMMS3409 - CARE-MS Extension | GENZYME CORPORATION | $478.61 | 1 |
| An Extension Protocol for Multiple Sclerosis patients Who Participated in Genzyme-sponsored Studies of Alemtuzumab | GENZYME CORPORATION | $452.74 | 1 |
| An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab | GENZYME CORPORATION | $219.90 | 1 |
| An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-sponsored Studies of Alemtuzumab | GENZYME CORPORATION | $145.20 | 1 |
About Dr. Mark Agius, MD
Dr. Mark Agius, MD is a Neurology healthcare provider based in Woodland, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/11/2005. The National Provider Identifier (NPI) number assigned to this provider is 1003897349.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Agius, MD has received a total of $741,919 in payments from pharmaceutical and medical device companies, with $37,008 received in 2020. These payments were reported across 775 transactions from 8 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($542,498).
Ad
Practice Information
- Specialty Neurology
- Location Woodland, CA
- Active Since 11/11/2005
- Last Updated 07/25/2017
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1003897349
Products in Payments
- AUBAGIO (Drug) $183,309
- GILENYA (Drug) $180,163
- LEMTRADA (Drug) $178,942
- Mavenclad (Biological) $55,572
- OCREVUS (Biological) $47,394
- Mavenclad (Drug) $33,383
- SOLIRIS (Drug) $16,508
- Ozanimod (Drug) $14,693
- MAYZENT (Drug) $9,876
- TECFIDERA (Drug) $467.43
- Aimovig (Biological) $121.86
- DISEASE STATE (Drug) $93.62
- Rebif (Biological) $4.92
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.